Avastin er, i kombination med interferon alfa 2a, indiceret til 1. linjebehandling af patienter med fremskreden og/ eller metastaserende renalcellecarcinom.
Avastin in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and/ or metastatic renal cell cancer.